Baidu
map

2013年国家自然科学基金医学类肿瘤学获批最多

2013-08-29 轻舟 生物谷

医学类独占鳌头项目数6985项,占总项目数的25%,获批项目金额也是最高,达到367041.2万元,占总金额23.3%。 从获批情况来看,肿瘤学最多,获批1531项,获批金额达79289.50。占获批总数和获批金额总数分别是22%,21.6% 表:医学类获批项目情况 学科名 项目数

医学类独占鳌头项目数6985项,占总项目数的25%,获批项目金额也是最高,达到367041.2万元,占总金额23.3%。

从获批情况来看,肿瘤学最多,获批1531项,获批金额达79289.50。占获批总数和获批金额总数分别是22%,21.6%

表:医学类获批项目情况

学科名 项目数 总金额(万元)
呼吸系统 161 8975.00
循环系统 462 24937.00
消化系统 233 11867.00
生殖系统/围生医学/新生儿 201 9630.00
泌尿系统 191 9463.00
运动系统 216 11814.00
内分泌系统/代谢和营养支持 209 11269.40
血液系统 163 7854.00
神经系统和精神疾病 546 28711.00
医学免疫学 203 10285.00
皮肤及其附属器 82 3827.00
眼科学 192 10311.00
耳鼻咽喉头颈科学 94 5332.00
口腔颅颌面科学 186 9537.00
急重症医学/创伤/烧伤/整形 145 7330.00
肿瘤学 1531 79289.50
康复医学 36 1723.00
影像医学与生物医学工程 381 20413.00
医学病原微生物与感染 188 10649.00
检验医学 57 2619.50
特种医学 10 730.00
放射医学 25 1333.00
法医学 37 1948.00
地方病学/职业病学 16 518.80
老年医学 40 2328.00
预防医学 239 13441.00
中医学 283 15133.00
中药学 240 11550.00
中西医结合 144 7116.00
药物学 229 14070.00
药理学 245 13037.00


图1:医学类获批项目数


图2:医学类金额数

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=9209, encodeId=8fa09209e5, content=非常有帮助啊,可惜护理类很少, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=761999770, createdName=wingjoy2009, createdTime=Wed Apr 30 13:16:00 CST 2014, time=2014-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7258, encodeId=e0b7e2580b, content=是不是有点扎堆了呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=682582219, createdName=jackduan, createdTime=Mon Feb 10 09:01:00 CST 2014, time=2014-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6556, encodeId=b871655670, content=很有帮助啊,是不是以后也向肿瘤发展?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=beb410623, createdName=sedesmd, createdTime=Mon Jan 06 12:58:00 CST 2014, time=2014-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661006, encodeId=78ff1661006bc, content=<a href='/topic/show?id=f8833421180' target=_blank style='color:#2F92EE;'>#医学类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34211, encryptionId=f8833421180, topicName=医学类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e73025182843, createdName=xiay994461, createdTime=Mon Dec 30 11:57:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6334, encodeId=a715633450, content=不错,目前在搞肿瘤转移机制的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43b89188, createdName=ajinhu, createdTime=Tue Dec 03 16:38:00 CST 2013, time=2013-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032893, encodeId=b891203289346, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Tue Dec 10 19:57:00 CST 2013, time=2013-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6267, encodeId=0118626e1a, content=国家自然科学基金(30572020), beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.67.161, createdTime=Thu Nov 07 10:12:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6187, encodeId=a47d618e56, content=以后的课题就写肿瘤相关专业的, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fef87990, createdName=linn18, createdTime=Sat Oct 05 10:56:00 CST 2013, time=2013-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337927, encodeId=270a133e92740, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390717, encodeId=624f1390e1735, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82896, encryptionId=8eeb828963a, topicName=肿瘤学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=)]
    2014-04-30 wingjoy2009

    非常有帮助啊,可惜护理类很少

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=9209, encodeId=8fa09209e5, content=非常有帮助啊,可惜护理类很少, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=761999770, createdName=wingjoy2009, createdTime=Wed Apr 30 13:16:00 CST 2014, time=2014-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7258, encodeId=e0b7e2580b, content=是不是有点扎堆了呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=682582219, createdName=jackduan, createdTime=Mon Feb 10 09:01:00 CST 2014, time=2014-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6556, encodeId=b871655670, content=很有帮助啊,是不是以后也向肿瘤发展?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=beb410623, createdName=sedesmd, createdTime=Mon Jan 06 12:58:00 CST 2014, time=2014-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661006, encodeId=78ff1661006bc, content=<a href='/topic/show?id=f8833421180' target=_blank style='color:#2F92EE;'>#医学类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34211, encryptionId=f8833421180, topicName=医学类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e73025182843, createdName=xiay994461, createdTime=Mon Dec 30 11:57:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6334, encodeId=a715633450, content=不错,目前在搞肿瘤转移机制的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43b89188, createdName=ajinhu, createdTime=Tue Dec 03 16:38:00 CST 2013, time=2013-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032893, encodeId=b891203289346, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Tue Dec 10 19:57:00 CST 2013, time=2013-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6267, encodeId=0118626e1a, content=国家自然科学基金(30572020), beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.67.161, createdTime=Thu Nov 07 10:12:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6187, encodeId=a47d618e56, content=以后的课题就写肿瘤相关专业的, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fef87990, createdName=linn18, createdTime=Sat Oct 05 10:56:00 CST 2013, time=2013-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337927, encodeId=270a133e92740, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390717, encodeId=624f1390e1735, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82896, encryptionId=8eeb828963a, topicName=肿瘤学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=)]
    2014-02-10 jackduan

    是不是有点扎堆了呢?

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=9209, encodeId=8fa09209e5, content=非常有帮助啊,可惜护理类很少, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=761999770, createdName=wingjoy2009, createdTime=Wed Apr 30 13:16:00 CST 2014, time=2014-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7258, encodeId=e0b7e2580b, content=是不是有点扎堆了呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=682582219, createdName=jackduan, createdTime=Mon Feb 10 09:01:00 CST 2014, time=2014-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6556, encodeId=b871655670, content=很有帮助啊,是不是以后也向肿瘤发展?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=beb410623, createdName=sedesmd, createdTime=Mon Jan 06 12:58:00 CST 2014, time=2014-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661006, encodeId=78ff1661006bc, content=<a href='/topic/show?id=f8833421180' target=_blank style='color:#2F92EE;'>#医学类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34211, encryptionId=f8833421180, topicName=医学类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e73025182843, createdName=xiay994461, createdTime=Mon Dec 30 11:57:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6334, encodeId=a715633450, content=不错,目前在搞肿瘤转移机制的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43b89188, createdName=ajinhu, createdTime=Tue Dec 03 16:38:00 CST 2013, time=2013-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032893, encodeId=b891203289346, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Tue Dec 10 19:57:00 CST 2013, time=2013-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6267, encodeId=0118626e1a, content=国家自然科学基金(30572020), beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.67.161, createdTime=Thu Nov 07 10:12:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6187, encodeId=a47d618e56, content=以后的课题就写肿瘤相关专业的, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fef87990, createdName=linn18, createdTime=Sat Oct 05 10:56:00 CST 2013, time=2013-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337927, encodeId=270a133e92740, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390717, encodeId=624f1390e1735, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82896, encryptionId=8eeb828963a, topicName=肿瘤学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=)]
    2014-01-06 sedesmd

    很有帮助啊,是不是以后也向肿瘤发展?

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=9209, encodeId=8fa09209e5, content=非常有帮助啊,可惜护理类很少, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=761999770, createdName=wingjoy2009, createdTime=Wed Apr 30 13:16:00 CST 2014, time=2014-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7258, encodeId=e0b7e2580b, content=是不是有点扎堆了呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=682582219, createdName=jackduan, createdTime=Mon Feb 10 09:01:00 CST 2014, time=2014-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6556, encodeId=b871655670, content=很有帮助啊,是不是以后也向肿瘤发展?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=beb410623, createdName=sedesmd, createdTime=Mon Jan 06 12:58:00 CST 2014, time=2014-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661006, encodeId=78ff1661006bc, content=<a href='/topic/show?id=f8833421180' target=_blank style='color:#2F92EE;'>#医学类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34211, encryptionId=f8833421180, topicName=医学类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e73025182843, createdName=xiay994461, createdTime=Mon Dec 30 11:57:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6334, encodeId=a715633450, content=不错,目前在搞肿瘤转移机制的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43b89188, createdName=ajinhu, createdTime=Tue Dec 03 16:38:00 CST 2013, time=2013-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032893, encodeId=b891203289346, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Tue Dec 10 19:57:00 CST 2013, time=2013-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6267, encodeId=0118626e1a, content=国家自然科学基金(30572020), beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.67.161, createdTime=Thu Nov 07 10:12:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6187, encodeId=a47d618e56, content=以后的课题就写肿瘤相关专业的, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fef87990, createdName=linn18, createdTime=Sat Oct 05 10:56:00 CST 2013, time=2013-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337927, encodeId=270a133e92740, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390717, encodeId=624f1390e1735, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82896, encryptionId=8eeb828963a, topicName=肿瘤学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=9209, encodeId=8fa09209e5, content=非常有帮助啊,可惜护理类很少, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=761999770, createdName=wingjoy2009, createdTime=Wed Apr 30 13:16:00 CST 2014, time=2014-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7258, encodeId=e0b7e2580b, content=是不是有点扎堆了呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=682582219, createdName=jackduan, createdTime=Mon Feb 10 09:01:00 CST 2014, time=2014-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6556, encodeId=b871655670, content=很有帮助啊,是不是以后也向肿瘤发展?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=beb410623, createdName=sedesmd, createdTime=Mon Jan 06 12:58:00 CST 2014, time=2014-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661006, encodeId=78ff1661006bc, content=<a href='/topic/show?id=f8833421180' target=_blank style='color:#2F92EE;'>#医学类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34211, encryptionId=f8833421180, topicName=医学类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e73025182843, createdName=xiay994461, createdTime=Mon Dec 30 11:57:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6334, encodeId=a715633450, content=不错,目前在搞肿瘤转移机制的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43b89188, createdName=ajinhu, createdTime=Tue Dec 03 16:38:00 CST 2013, time=2013-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032893, encodeId=b891203289346, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Tue Dec 10 19:57:00 CST 2013, time=2013-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6267, encodeId=0118626e1a, content=国家自然科学基金(30572020), beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.67.161, createdTime=Thu Nov 07 10:12:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6187, encodeId=a47d618e56, content=以后的课题就写肿瘤相关专业的, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fef87990, createdName=linn18, createdTime=Sat Oct 05 10:56:00 CST 2013, time=2013-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337927, encodeId=270a133e92740, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390717, encodeId=624f1390e1735, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82896, encryptionId=8eeb828963a, topicName=肿瘤学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=)]
    2013-12-03 ajinhu

    不错,目前在搞肿瘤转移机制的研究

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=9209, encodeId=8fa09209e5, content=非常有帮助啊,可惜护理类很少, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=761999770, createdName=wingjoy2009, createdTime=Wed Apr 30 13:16:00 CST 2014, time=2014-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7258, encodeId=e0b7e2580b, content=是不是有点扎堆了呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=682582219, createdName=jackduan, createdTime=Mon Feb 10 09:01:00 CST 2014, time=2014-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6556, encodeId=b871655670, content=很有帮助啊,是不是以后也向肿瘤发展?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=beb410623, createdName=sedesmd, createdTime=Mon Jan 06 12:58:00 CST 2014, time=2014-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661006, encodeId=78ff1661006bc, content=<a href='/topic/show?id=f8833421180' target=_blank style='color:#2F92EE;'>#医学类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34211, encryptionId=f8833421180, topicName=医学类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e73025182843, createdName=xiay994461, createdTime=Mon Dec 30 11:57:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6334, encodeId=a715633450, content=不错,目前在搞肿瘤转移机制的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43b89188, createdName=ajinhu, createdTime=Tue Dec 03 16:38:00 CST 2013, time=2013-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032893, encodeId=b891203289346, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Tue Dec 10 19:57:00 CST 2013, time=2013-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6267, encodeId=0118626e1a, content=国家自然科学基金(30572020), beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.67.161, createdTime=Thu Nov 07 10:12:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6187, encodeId=a47d618e56, content=以后的课题就写肿瘤相关专业的, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fef87990, createdName=linn18, createdTime=Sat Oct 05 10:56:00 CST 2013, time=2013-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337927, encodeId=270a133e92740, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390717, encodeId=624f1390e1735, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82896, encryptionId=8eeb828963a, topicName=肿瘤学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=9209, encodeId=8fa09209e5, content=非常有帮助啊,可惜护理类很少, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=761999770, createdName=wingjoy2009, createdTime=Wed Apr 30 13:16:00 CST 2014, time=2014-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7258, encodeId=e0b7e2580b, content=是不是有点扎堆了呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=682582219, createdName=jackduan, createdTime=Mon Feb 10 09:01:00 CST 2014, time=2014-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6556, encodeId=b871655670, content=很有帮助啊,是不是以后也向肿瘤发展?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=beb410623, createdName=sedesmd, createdTime=Mon Jan 06 12:58:00 CST 2014, time=2014-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661006, encodeId=78ff1661006bc, content=<a href='/topic/show?id=f8833421180' target=_blank style='color:#2F92EE;'>#医学类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34211, encryptionId=f8833421180, topicName=医学类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e73025182843, createdName=xiay994461, createdTime=Mon Dec 30 11:57:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6334, encodeId=a715633450, content=不错,目前在搞肿瘤转移机制的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43b89188, createdName=ajinhu, createdTime=Tue Dec 03 16:38:00 CST 2013, time=2013-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032893, encodeId=b891203289346, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Tue Dec 10 19:57:00 CST 2013, time=2013-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6267, encodeId=0118626e1a, content=国家自然科学基金(30572020), beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.67.161, createdTime=Thu Nov 07 10:12:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6187, encodeId=a47d618e56, content=以后的课题就写肿瘤相关专业的, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fef87990, createdName=linn18, createdTime=Sat Oct 05 10:56:00 CST 2013, time=2013-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337927, encodeId=270a133e92740, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390717, encodeId=624f1390e1735, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82896, encryptionId=8eeb828963a, topicName=肿瘤学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=)]
    2013-11-07 175.8.67.161

    国家自然科学基金(30572020)

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=9209, encodeId=8fa09209e5, content=非常有帮助啊,可惜护理类很少, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=761999770, createdName=wingjoy2009, createdTime=Wed Apr 30 13:16:00 CST 2014, time=2014-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7258, encodeId=e0b7e2580b, content=是不是有点扎堆了呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=682582219, createdName=jackduan, createdTime=Mon Feb 10 09:01:00 CST 2014, time=2014-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6556, encodeId=b871655670, content=很有帮助啊,是不是以后也向肿瘤发展?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=beb410623, createdName=sedesmd, createdTime=Mon Jan 06 12:58:00 CST 2014, time=2014-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661006, encodeId=78ff1661006bc, content=<a href='/topic/show?id=f8833421180' target=_blank style='color:#2F92EE;'>#医学类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34211, encryptionId=f8833421180, topicName=医学类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e73025182843, createdName=xiay994461, createdTime=Mon Dec 30 11:57:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6334, encodeId=a715633450, content=不错,目前在搞肿瘤转移机制的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43b89188, createdName=ajinhu, createdTime=Tue Dec 03 16:38:00 CST 2013, time=2013-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032893, encodeId=b891203289346, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Tue Dec 10 19:57:00 CST 2013, time=2013-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6267, encodeId=0118626e1a, content=国家自然科学基金(30572020), beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.67.161, createdTime=Thu Nov 07 10:12:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6187, encodeId=a47d618e56, content=以后的课题就写肿瘤相关专业的, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fef87990, createdName=linn18, createdTime=Sat Oct 05 10:56:00 CST 2013, time=2013-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337927, encodeId=270a133e92740, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390717, encodeId=624f1390e1735, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82896, encryptionId=8eeb828963a, topicName=肿瘤学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=)]
    2013-10-05 linn18

    以后的课题就写肿瘤相关专业的

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=9209, encodeId=8fa09209e5, content=非常有帮助啊,可惜护理类很少, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=761999770, createdName=wingjoy2009, createdTime=Wed Apr 30 13:16:00 CST 2014, time=2014-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7258, encodeId=e0b7e2580b, content=是不是有点扎堆了呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=682582219, createdName=jackduan, createdTime=Mon Feb 10 09:01:00 CST 2014, time=2014-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6556, encodeId=b871655670, content=很有帮助啊,是不是以后也向肿瘤发展?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=beb410623, createdName=sedesmd, createdTime=Mon Jan 06 12:58:00 CST 2014, time=2014-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661006, encodeId=78ff1661006bc, content=<a href='/topic/show?id=f8833421180' target=_blank style='color:#2F92EE;'>#医学类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34211, encryptionId=f8833421180, topicName=医学类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e73025182843, createdName=xiay994461, createdTime=Mon Dec 30 11:57:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6334, encodeId=a715633450, content=不错,目前在搞肿瘤转移机制的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43b89188, createdName=ajinhu, createdTime=Tue Dec 03 16:38:00 CST 2013, time=2013-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032893, encodeId=b891203289346, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Tue Dec 10 19:57:00 CST 2013, time=2013-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6267, encodeId=0118626e1a, content=国家自然科学基金(30572020), beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.67.161, createdTime=Thu Nov 07 10:12:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6187, encodeId=a47d618e56, content=以后的课题就写肿瘤相关专业的, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fef87990, createdName=linn18, createdTime=Sat Oct 05 10:56:00 CST 2013, time=2013-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337927, encodeId=270a133e92740, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390717, encodeId=624f1390e1735, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82896, encryptionId=8eeb828963a, topicName=肿瘤学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=)]
  10. [GetPortalCommentsPageByObjectIdResponse(id=9209, encodeId=8fa09209e5, content=非常有帮助啊,可惜护理类很少, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=761999770, createdName=wingjoy2009, createdTime=Wed Apr 30 13:16:00 CST 2014, time=2014-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7258, encodeId=e0b7e2580b, content=是不是有点扎堆了呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=682582219, createdName=jackduan, createdTime=Mon Feb 10 09:01:00 CST 2014, time=2014-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6556, encodeId=b871655670, content=很有帮助啊,是不是以后也向肿瘤发展?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=beb410623, createdName=sedesmd, createdTime=Mon Jan 06 12:58:00 CST 2014, time=2014-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661006, encodeId=78ff1661006bc, content=<a href='/topic/show?id=f8833421180' target=_blank style='color:#2F92EE;'>#医学类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34211, encryptionId=f8833421180, topicName=医学类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e73025182843, createdName=xiay994461, createdTime=Mon Dec 30 11:57:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6334, encodeId=a715633450, content=不错,目前在搞肿瘤转移机制的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43b89188, createdName=ajinhu, createdTime=Tue Dec 03 16:38:00 CST 2013, time=2013-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032893, encodeId=b891203289346, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Tue Dec 10 19:57:00 CST 2013, time=2013-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6267, encodeId=0118626e1a, content=国家自然科学基金(30572020), beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.67.161, createdTime=Thu Nov 07 10:12:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6187, encodeId=a47d618e56, content=以后的课题就写肿瘤相关专业的, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fef87990, createdName=linn18, createdTime=Sat Oct 05 10:56:00 CST 2013, time=2013-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337927, encodeId=270a133e92740, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390717, encodeId=624f1390e1735, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82896, encryptionId=8eeb828963a, topicName=肿瘤学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sat Aug 31 09:57:00 CST 2013, time=2013-08-31, status=1, ipAttribution=)]

相关资讯

Cell:细胞如何给自己缓压?

自由基就像燃烧废气一样,是由于外部能源或细胞代谢所产生,会对机体细胞造成压力。人们认为细胞压力促进了癌症、神经退行性疾病和代谢性疾病等年龄相关疾病的发生。 现在,来自德国弗莱堡大学的研究人员揭示出了细胞保护自身免受压力伤害的一条新机制。他们发现,许多细胞中很少研究的一个元件 Astrin 在这一过程中发挥了重要的作用。尽管过去已知 Astrin 在细胞分裂中所起的作用,这

Nature:癌症突变具有不同特征

尽管所有癌症都被认为是由体细胞突变(身体中除生殖细胞以外的任何细胞的突变)造成的,但我们对所涉及的突变过程相对来说却知之甚少。这项研究分析了来自超过7000癌症的近500万突变,发现了超过20个与癌症相关的不同突变特征。这些特征中有些存在于很多癌症中,其中一个特征属于APOBEC家族的胞苷脱氨酶,而其他特征则是个别肿瘤类型特有的。有些特征与年龄、已知诱变因素或DNA维护中的缺陷有关,但很多的来源却

PNAS:解答10年谜题:eIF4E蛋白与癌症

很久以前研究人员就已经知道,人类细胞中一种特异的蛋白质高水平与肿瘤生长相关,但却对这一具体机制却不是很清楚。 现在,来自加州大学戴维斯分校生命科学学院的研究人员取得了一项突破性的发现,他们阐明了真核起始因子 4E(eukaryotic initiation factor 4E, eIF4E )蛋白对促癌信使 RNA 分子起作用的机制。当翻译之时,这类 mRNA 可以触发失控性

Genome Res:可以有效寻找癌症、糖尿病基因的预测模型

来自延世大学李仁锡教授,利用'机能遗传子网络'预测模型,开发的可以有效地发掘调解复杂疾患遗传子的新方法。 此次研究是通过与欧洲分子生物学研究所的Lehner博士,德克萨斯州立大学的Marcotte博士,加拿大多伦多大学的Fraser博士的国际共同研究所进行的研究,也是得到教科部及韩国研究财团的'优秀研究中心(S/ERC)育成事业'与'一半研究者支援事业'支援的随性研究。 李仁锡教授研究组利用'

Lancet Oncol:TERT启动子UTSS区域高度甲基化是儿童脑肿瘤进展的预测标记

研究要点:TERT启动子甲基化可作为儿童恶性脑肿瘤的生物标记和预后判断标记。在儿童恶性脑肿瘤中,当肿瘤从低级别向高级别转化时,UTSS甲基化增加。TERT启动子UTSS区域的高度甲基化与肿瘤中TERT的表达相关。在儿科神经系统肿瘤领域中,鉴定得到对恶性疾病有提示意义的生物标记是十分重要的方面。这有助于建立评估疾病出现进展的方法。加拿大多伦多大学的Pedro Castelo-Branco等为了探

Nat Biotechnol:科学家利用干细胞制造大量可靶向肿瘤的免疫细胞

近日,纪念斯隆-凯特林癌症中心的科学家发明了一种利用干细胞制造出大量可杀死小鼠体内肿瘤细胞的人免疫细胞的新技术。该技术或能让癌症免疫疗法这种通过激活免疫系统来消灭肿瘤的治疗方法更容易获得实施。相关研究论文刊登在了近期出版的Nature Biotechnology杂志上。【原文下载】 大多数癌症免疫疗法需要从病人血液中分离出T细胞这种免疫细胞。但是,能够杀死特定肿瘤细胞而不

Baidu
map
Baidu
map
Baidu
map